Treatment of Recurrent Platinum-Resistant Ovarian Cancer with Pegylated Liposomal Doxorubicin – An Evaluation of the Therapeutic Index with Special Emphasis on Cardiac Toxicity

By  

Chemotherapy, Vol. 55, Iss. 6, 2009-11 ,pp. : 391-398

Karger

Access to resources Recommend Favorite

Chemokine Receptors in Epithelial Ovarian Cancer

By Muralidhar Goda G.   Barbolina Maria V.  

International Journal of Molecular Sciences, Vol. 15, Iss. 1, 2013-12 ,pp. : 361-376

MDPI

Access to resources Recommend Favorite

Targeted Therapies in Epithelial Ovarian Cancer

By Dean Emma   El-Helw Loaie   Hasan Jurjees  

Cancers, Vol. 2, Iss. 1, 2010-02 ,pp. : 88-113

MDPI

Access to resources Recommend Favorite

Pre-Treatment of Platinum Resistant Ovarian Cancer Cells with an MMP-9/MMP-2 Inhibitor Prior to Cisplatin Enhances Cytotoxicity as Determined by High Content Screening

By Laios Alexandros   Mohamed Bashir M.   Kelly Lynne   Flavin Richard   Finn Stephen   McEvoy Lynda   Gallagher Michael   Martin Cara   Sheils Orla   Ring Martina   Davies Anthony   Lawson Margaret   Gleeson Noreen   D’Arcy Tom   d’Adhemar Charles   Norris Lucy   Langhe Ream   Saadeh Feras Abu   O’Leary John J.   O’Toole Sharon A.  

International Journal of Molecular Sciences, Vol. 14, Iss. 1, 2013-01 ,pp. : 2085-2103

MDPI

Access to resources Recommend Favorite

Targeting Signaling Pathways in Epithelial Ovarian Cancer

By Smolle Elisabeth   Taucher Valentin   Pichler Martin   Petru Edgar   Lax Sigurd   Haybaeck Johannes  

International Journal of Molecular Sciences, Vol. 14, Iss. 5, 2013-05 ,pp. : 9536-9555

MDPI

Access to resources Recommend Favorite